The
report " Growth Hormone Secretagogue Receptor Type 1 (GHS-R or
GH-Releasing Peptide Receptor or GHRP or Ghrelin Receptor or GHSR) -
Pipeline Review, H1 2016 ", has been prepared based on an
in-depth market analysis with inputs from industry experts.
Global
Markets Directs, Growth
Hormone Secretagogue Receptor Type 1 (GHS-R
or GH-Releasing Peptide Receptor or GHRP or Ghrelin Receptor or GHSR)
- Pipeline Review, H1 2016, provides in depth analysis on Growth
Hormone Secretagogue Receptor Type 1 (GHS-R or GH-Releasing Peptide
Receptor or GHRP or Ghrelin Receptor or GHSR) targeted pipeline
therapeutics.
The
report provides comprehensive information on the Growth Hormone
Secretagogue Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor
or GHRP or Ghrelin Receptor or GHSR), targeted therapeutics, complete
with analysis by indications, stage of development, mechanism of
action (MoA), route of administration (RoA) and molecule type. The
report also covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and
latest news and press releases. Additionally, the report provides an
overview of key players involved in Growth Hormone Secretagogue
Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or
Ghrelin Receptor or GHSR) targeted therapeutics development and
features dormant and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download
Sample copy of this Report @
Scope
-
The report provides a snapshot of the global therapeutic landscape
for Growth Hormone Secretagogue Receptor Type 1 (GHS-R or
GH-Releasing Peptide Receptor or GHRP or Ghrelin Receptor or GHSR)
-
The report reviews Growth Hormone Secretagogue Receptor Type 1 (GHS-R
or GH-Releasing Peptide Receptor or GHRP or Ghrelin Receptor or GHSR)
targeted therapeutics under development by companies and
universities/research institutes based on information derived from
company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved in Growth Hormone
Secretagogue Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor
or GHRP or Ghrelin Receptor or GHSR) targeted therapeutics and
enlists all their major and minor projects
-
The report assesses Growth Hormone Secretagogue Receptor Type 1
(GHS-R or GH-Releasing Peptide Receptor or GHRP or Ghrelin Receptor
or GHSR) targeted therapeutics based on mechanism of action (MoA),
route of administration (RoA) and molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news and deals related to Growth Hormone
Secretagogue Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor
or GHRP or Ghrelin Receptor or GHSR) targeted therapeutics
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand the targeted therapy areas and indications
for Growth Hormone Secretagogue Receptor Type 1 (GHS-R or
GH-Releasing Peptide Receptor or GHRP or Ghrelin Receptor or GHSR)
-
Identify the use of drugs for target identification and drug
repurposing
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Growth Hormone Secretagogue Receptor Type 1 (GHS-R or GH-Releasing
Peptide Receptor or GHRP or Ghrelin Receptor or GHSR) development
landscape
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
Browse All reports Of this
Category:www.marketresearchreports.biz/category/38
Table
of Content :
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report
Coverage 7
Growth Hormone Secretagogue
Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or
Ghrelin Receptor or GHSR) Overview 8
Therapeutics Development 9
Growth Hormone Secretagogue
Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or
Ghrelin Receptor or GHSR) - Products under Development by Stage of
Development 9
Growth Hormone Secretagogue
Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or
Ghrelin Receptor or GHSR) - Products under Development by Therapy
Area 10
Growth Hormone Secretagogue
Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or
Ghrelin Receptor or GHSR) - Products under Development by Indication
11
Growth Hormone Secretagogue
Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or
Ghrelin Receptor or GHSR) - Pipeline Products Glance 12
Late Stage Products 12
Early Stage Products 13
Growth Hormone Secretagogue
Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or
Ghrelin Receptor or GHSR) - Products under Development by Companies
14
Growth Hormone Secretagogue
Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or
Ghrelin Receptor or GHSR) - Products under Development by
Universities/Institutes 17
Growth Hormone Secretagogue
Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or
Ghrelin Receptor or GHSR) - Therapeutics Assessment 19
Assessment by
Monotherapy/Combination Products 19
Assessment by Mechanism of
Action 20
Assessment by Route of
Administration 22
Assessment by Molecule Type 24
Growth Hormone Secretagogue
Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or
Ghrelin Receptor or GHSR) - Companies Involved in Therapeutics
Development 26
AstraZeneca Plc 26
Aeterna Zentaris Inc. 27
Asubio Pharma Co., Ltd. 28
Asubio Pharma Co., Ltd. 28
Alize Pharma SAS 29
Helsinn Healthcare S.A. 30
Pfizer Inc. 31
RaQualia Pharma Inc. 32
Rhythm Pharmaceuticals, Inc. 33
Growth Hormone Secretagogue
Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or
Ghrelin Receptor or GHSR) - Drug Profiles 34
anamorelin hydrochloride - Drug
Profile 34
Product Description 34
Mechanism Of Action 34
R&D Progress 34
AZ-12861903 - Drug Profile 38
Product Description 38
Mechanism Of Action 38
R&D Progress 38
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
us:
Mr.
Nachiket
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA:
Canada Toll Free: 866-997-4948
No comments:
Post a Comment